Legacy Financial Advisors’s Boston Scientific BSX Stock Holding History

Legacy Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$392K	Buy	6,251 +1,295	+26%	+$104K	0.05%	273
2025 Q4	$473K	Sell	4,956 -759	-13%	-$74.4K	0.07%	231
2025 Q3	$558K	Sell	5,715 -1,079	-16%	-$112K	0.08%	213
2025 Q2	$730K	Buy	6,794 +1,218	+22%	+$123K	0.11%	158
2025 Q1	$563K	Buy	5,576 +256	+5%	+$25.8K	0.09%	176
2024 Q4	$475K	Buy	5,320 +1,343	+34%	+$118K	0.08%	199
2024 Q3	$333K	Sell	3,977 -130	-3%	-$10.2K	0.06%	257
2024 Q2	$316K	Buy	4,107 +247	+6%	+$18.1K	0.06%	242
2024 Q1	$264K	Sell	3,860 -13	-0.3%	-$836	0.05%	266
2023 Q4	$224K	Buy	+3,873	New	+$207K	0.04%	275
2019 Q2	–	Sell	-464	Closed	-$18K	–	228
2019 Q1	$18K	Buy	464 +413	+810%	+$15.8K	0.01%	471
2018 Q4	$2K	Sell	51 -103	-67%	-$3.74K	﹤0.01%	833
2018 Q3	$5K	Hold	154	–	–	﹤0.01%	676
2018 Q2	$5K	Buy	+154	New	+$4.64K	﹤0.01%	686
2018 Q1	–	Sell	-108	Closed	-$2K	–	823
2017 Q4	$2K	Buy	+108	New	+$2.98K	﹤0.01%	729

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Legacy Financial Advisors's BSX Position: Q1 2026 in Review

Legacy Financial Advisors increased its Boston Scientific (BSX) stake by 26% in Q1 2026, buying an estimated $104K and bringing the position to 6,251 shares worth $392K. The position accounts for 0.05% of the portfolio, ranked #273.

Legacy Financial Advisors first reported a position in BSX in Q4 2017 and has held it in 15 quarters since. The position peaked at $730K in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Legacy Financial Advisors held 6,251 shares of Boston Scientific worth $392K as of Q1 2026.
Legacy Financial Advisors bought 1,295 Boston Scientific shares in Q1 2026, an estimated $104K.
Boston Scientific made up 0.05% of Legacy Financial Advisors's portfolio in Q1 2026, its #273 holding.
Legacy Financial Advisors first reported a position in Boston Scientific in Q4 2017 and has held it in 15 quarters since.
Legacy Financial Advisors's Boston Scientific position peaked at $730K in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Legacy Financial Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.